S Yurdakul

Summary

Affiliation: Istanbul University
Country: Turkey

Publications

  1. ncbi A double-blind trial of colchicine in Behçet's syndrome
    S Yurdakul
    Behçet s Syndrome Research Center, Cerrahpasa Medical School, University of Istanbul, Turkey
    Arthritis Rheum 44:2686-92. 2001
  2. ncbi Inefficacy of azapropazone in the acute arthritis of Behçet's syndrome: a randomized, double blind, placebo controlled study
    F Moral
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Clin Exp Rheumatol 13:493-5. 1995
  3. ncbi A reappraisal of amyloidosis in Behçet's syndrome
    M Melikoglu
    Department of Rheumatology, Cerrahpasa Medical School, University of Istanbul, Istanbul, Turkey
    Rheumatology (Oxford) 40:212-5. 2001
  4. ncbi Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome
    I Fresko
    Behçet s Syndrome Research Center, Cerrahpasa Medical Faculty, Istanbul, Turkey
    Clin Exp Rheumatol 23:S67-70. 2005
  5. ncbi A cost analysis of Behcet's syndrome in Turkey
    N Sut
    Department of Biostatistics, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Rheumatology (Oxford) 46:678-82. 2007
  6. ncbi Secondary amyloidosis in progressive systemic sclerosis
    G E Pamuk
    Cerrahpasa Medical School, University of Istanbul, Turkey
    Clin Rheumatol 20:285-7. 2001
  7. ncbi Fibrinolytic activity and d-dimer levels in Behçet's syndrome
    S Yurdakul
    Behçet s Syndrome Research Center, Istanbul, Turkey
    Clin Exp Rheumatol 23:S53-8. 2005
  8. ncbi EULAR recommendations for the management of Behçet disease
    G Hatemi
    Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Ann Rheum Dis 67:1656-62. 2008
  9. ncbi Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease
    G Hatemi
    Department of Internal Medicine, Division of Rheumatology, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Ann Rheum Dis 68:1528-34. 2009

Collaborators

Detail Information

Publications9

  1. ncbi A double-blind trial of colchicine in Behçet's syndrome
    S Yurdakul
    Behçet s Syndrome Research Center, Cerrahpasa Medical School, University of Istanbul, Turkey
    Arthritis Rheum 44:2686-92. 2001
    ..We reassessed the effect of colchicine in Behçet's syndrome in a study conducted among a larger group of patients for 2 years...
  2. ncbi Inefficacy of azapropazone in the acute arthritis of Behçet's syndrome: a randomized, double blind, placebo controlled study
    F Moral
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Clin Exp Rheumatol 13:493-5. 1995
    ..05). There were also no differences in the mean numbers of acetaminophen tablets used or in the CRP and ESR levels between the two groups. We conclude that azapropazone is not effective in controlling the arthritis of Behçet's syndrome...
  3. ncbi A reappraisal of amyloidosis in Behçet's syndrome
    M Melikoglu
    Department of Rheumatology, Cerrahpasa Medical School, University of Istanbul, Istanbul, Turkey
    Rheumatology (Oxford) 40:212-5. 2001
    ..To evaluate the clinical features and outcome of patients with Behçet's syndrome (BS) and amyloidosis and to assess the associated risk factors...
  4. ncbi Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome
    I Fresko
    Behçet s Syndrome Research Center, Cerrahpasa Medical Faculty, Istanbul, Turkey
    Clin Exp Rheumatol 23:S67-70. 2005
    ..Increased as well as normal levels have been reported in Behçet's syndrome (BS). We reassessed the level of IgG and IgA ASCA antibodies in BS and in a group of diseased and healthy controls...
  5. ncbi A cost analysis of Behcet's syndrome in Turkey
    N Sut
    Department of Biostatistics, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Rheumatology (Oxford) 46:678-82. 2007
    ..Behçet's syndrome (BS), a common chronic inflammatory disease in Turkey, results in considerable morbidity and increased mortality. We aimed to estimate its direct and indirect costs...
  6. ncbi Secondary amyloidosis in progressive systemic sclerosis
    G E Pamuk
    Cerrahpasa Medical School, University of Istanbul, Turkey
    Clin Rheumatol 20:285-7. 2001
    ..He died from massive upper gastrointestinal bleeding caused by oesophageal telangiectasia...
  7. ncbi Fibrinolytic activity and d-dimer levels in Behçet's syndrome
    S Yurdakul
    Behçet s Syndrome Research Center, Istanbul, Turkey
    Clin Exp Rheumatol 23:S53-8. 2005
    ..We have studied tissue-type plasminogen activator (t-PA) and its inhibitor (PAI-1), and d-dimer levels in BS patients with and without thrombosis both in the acute and chronic phases along with suitable diseased and healthy controls...
  8. ncbi EULAR recommendations for the management of Behçet disease
    G Hatemi
    Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Ann Rheum Dis 67:1656-62. 2008
    ..To develop evidence-based European League Against Rheumatism (EULAR) recommendations for the management of Behçet disease (BD) supplemented where necessary by expert opinion...
  9. ncbi Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease
    G Hatemi
    Department of Internal Medicine, Division of Rheumatology, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey
    Ann Rheum Dis 68:1528-34. 2009
    ....